Trial Profile
Phase II trial of topotecan, cisplatin and bevacizumab for recurrent/persistent cervical cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Topotecan (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Aug 2011 Planned End Date changed from 1 Mar 2010 to 1 Mar 2012 as reported by ClinicalTrials.gov.